Readiness of the Stroke Treatment in India: Still an Uphill Task!
- PMID: 37719342
- PMCID: PMC10504654
- DOI: 10.5005/jp-journals-10071-24525
Readiness of the Stroke Treatment in India: Still an Uphill Task!
Abstract
How to cite this article: Singhal V, Prabhakar H. Readiness of the Stroke Treatment in India: Still an Uphill Task! Indian J Crit Care Med 2023;27(9):607-608.
Keywords: Acute Ischemic stroke; Intravenous thrombolytic therapy; Low resources settings.
Copyright © 2023; The Author(s).
Conflict of interest statement
Source of support: Nil Conflict of interest: None
References
-
- Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282(21):2019–2026. doi: 10.1001/jama.282.21.2019. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources